Anti-VEGF Therapeutics Market Size, Share & Trends Analysis Report By Product (Eylea, Lucentis, Beovu, Vabysmo, Others), By Disease Type (Macular Edema, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration, Myopic Choroidal Neovascularization) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: September 07, 2026 | Author: Debashree Bora | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Anti-VEGF Therapeutics Market Size Analysis
    1. Introduction
    2. Anti-VEGF Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Eylea
      2. Lucentis
      3. Beovu
      4. Vabysmo
      5. Others
    3. Anti-VEGF Therapeutics Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Macular Edema
      2. Diabetic Retinopathy
      3. Retinal Vein Occlusion
      4. Age-related Macular Degeneration
      5. Myopic Choroidal Neovascularization
  7. North America Anti-VEGF Therapeutics Market Size Analysis
    1. Introduction
    2. Anti-VEGF Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Eylea
      2. Lucentis
      3. Beovu
      4. Vabysmo
      5. Others
    3. Anti-VEGF Therapeutics Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Macular Edema
      2. Diabetic Retinopathy
      3. Retinal Vein Occlusion
      4. Age-related Macular Degeneration
      5. Myopic Choroidal Neovascularization
    4. U.S.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    5. Canada
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
  8. Europe Anti-VEGF Therapeutics Market Size Analysis
    1. Introduction
    2. Anti-VEGF Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Eylea
      2. Lucentis
      3. Beovu
      4. Vabysmo
      5. Others
    3. Anti-VEGF Therapeutics Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Macular Edema
      2. Diabetic Retinopathy
      3. Retinal Vein Occlusion
      4. Age-related Macular Degeneration
      5. Myopic Choroidal Neovascularization
    4. U.K.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    5. Germany
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    6. France
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    7. Spain
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    8. Italy
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    9. Russia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    10. Nordic
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    11. Benelux
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    12. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
  9. APAC Anti-VEGF Therapeutics Market Size Analysis
    1. Introduction
    2. Anti-VEGF Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Eylea
      2. Lucentis
      3. Beovu
      4. Vabysmo
      5. Others
    3. Anti-VEGF Therapeutics Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Macular Edema
      2. Diabetic Retinopathy
      3. Retinal Vein Occlusion
      4. Age-related Macular Degeneration
      5. Myopic Choroidal Neovascularization
    4. China
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    5. Korea
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    6. Japan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    7. India
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    8. Australia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    9. Taiwan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    10. South East Asia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    11. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
  10. Middle East and Africa Anti-VEGF Therapeutics Market Size Analysis
    1. Introduction
    2. Anti-VEGF Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Eylea
      2. Lucentis
      3. Beovu
      4. Vabysmo
      5. Others
    3. Anti-VEGF Therapeutics Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Macular Edema
      2. Diabetic Retinopathy
      3. Retinal Vein Occlusion
      4. Age-related Macular Degeneration
      5. Myopic Choroidal Neovascularization
    4. UAE
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    5. Turkey
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    6. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    7. South Africa
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    8. Egypt
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    9. Nigeria
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    10. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
  11. LATAM Anti-VEGF Therapeutics Market Size Analysis
    1. Introduction
    2. Anti-VEGF Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Eylea
      2. Lucentis
      3. Beovu
      4. Vabysmo
      5. Others
    3. Anti-VEGF Therapeutics Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Macular Edema
      2. Diabetic Retinopathy
      3. Retinal Vein Occlusion
      4. Age-related Macular Degeneration
      5. Myopic Choroidal Neovascularization
    4. Brazil
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    5. Mexico
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    6. Argentina
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    7. Chile
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    8. Colombia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    9. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
  12. Competitive Landscape
    1. Anti-VEGF Therapeutics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Regeneron Pharmaceuticals, Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Bayer AG
    3. Novartis AG
    4. Hoffmann-La Roche Ltd.
    5. Frensius Kabi
    6. Biogen
    7. Pfizer, Inc.
    8. Alvotech
    9. Teva Pharmaceuticals
    10. Coherus Biosciences, Inc.
    11. Amgen, Inc.
    12. Bausch Health Companies, Inc.
    13. Viatris, Inc.
    14. Sanofi
    15. Isarna Therapeutics
    16. Genentech
    17. SamChunDang Pharm
    18. Roche
    19. Formycon AG
    20. Bioeq AG
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

List of Tables

Table 1: Global Anti-VEGF Therapeutics Market Size and Forecast By Regions - 2022-2034 (USD Billion)

Table 2: Global Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 3: Global Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 4: North America Anti-VEGF Therapeutics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 5: North America Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 6: North America Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 7: U.S. Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 8: U.S. Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 9: Canada Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 10: Canada Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 11: Europe Anti-VEGF Therapeutics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 12: Europe Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 13: Europe Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 14: U.K. Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 15: U.K. Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 16: Germany Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 17: Germany Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 18: France Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 19: France Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 20: Spain Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 21: Spain Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 22: Italy Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 23: Italy Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 24: Russia Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 25: Russia Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 26: Nordic Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 27: Nordic Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 28: Benelux Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 29: Benelux Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 30: Rest of Europe Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 31: Rest of Europe Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 32: APAC Anti-VEGF Therapeutics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 33: APAC Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 34: APAC Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 35: China Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 36: China Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 37: Korea Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 38: Korea Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 39: Japan Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 40: Japan Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 41: India Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 42: India Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 43: Australia Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 44: Australia Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 45: Taiwan Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 46: Taiwan Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 47: South East Asia Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 48: South East Asia Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 49: Rest of Asia-Pacific Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 50: Rest of Asia-Pacific Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 51: Middle East and Africa Anti-VEGF Therapeutics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 52: Middle East and Africa Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 53: Middle East and Africa Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 54: UAE Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 55: UAE Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 56: Turkey Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 57: Turkey Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 58: Saudi Arabia Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 59: Saudi Arabia Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 60: South Africa Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 61: South Africa Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 62: Egypt Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 63: Egypt Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 64: Nigeria Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 65: Nigeria Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 66: Rest of MEA Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 67: Rest of MEA Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 68: LATAM Anti-VEGF Therapeutics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 69: LATAM Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 70: LATAM Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 71: Brazil Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 72: Brazil Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 73: Mexico Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 74: Mexico Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 75: Argentina Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 76: Argentina Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 77: Chile Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 78: Chile Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 79: Colombia Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 80: Colombia Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

Table 81: Rest of LATAM Anti-VEGF Therapeutics Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 82: Rest of LATAM Anti-VEGF Therapeutics Market Size and Forecast By Disease Type - 2022-2034 (USD Billion)

We are featured on: